In this study, we explored the association between CYP2D6 metabolizer phenotype and mammographic density change, using breast cancer cases from a population-based breast cancer case–control study conducted in Sweden between 1993 and 1995 [8-10]. The gene discussed is CYP2D6; the disease is breast cancer.